67 related articles for article (PubMed ID: 8741150)
1. Apoptotic cell death in proliferative vitreoretinopathy.
Esser P; Bartz-Schmidt KU; Walter P; Kaszli F; Heimann K; Weller M
Ger J Ophthalmol; 1996 Mar; 5(2):73-8. PubMed ID: 8741150
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy.
Esser P; Tervooren D; Heimann K; Kociok N; Bartz-Schmidt KU; Walter P; Weller M
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):164-70. PubMed ID: 9430558
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
Lashkari K; Rahimi N; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438
[TBL] [Abstract][Full Text] [Related]
6. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
7. CD 95 expression in traumatic proliferative vitreoretinopathy: a target for the induction of apoptosis.
Weller M; Heimann K; Bartz-Schmidt KU; Fontana A; Esser P
Ger J Ophthalmol; 1996 Nov; 5(6):332-7. PubMed ID: 9479514
[TBL] [Abstract][Full Text] [Related]
8. Genistein produces reduction in growth and induces apoptosis of rat RPE-J cells.
Yoon HS; Rho SH; Jeong JH; Yoon S; Yoo KS; Yoo YH
Curr Eye Res; 2000 Mar; 20(3):215-24. PubMed ID: 10694898
[TBL] [Abstract][Full Text] [Related]
9. [The role of apoptosis in physiology and pathology of the retina].
Obuchowska I; Stankiewicz A
Klin Oczna; 1999; 101(2):139-43. PubMed ID: 10418241
[TBL] [Abstract][Full Text] [Related]
10. The properties of retinal pigment epithelial cells in proliferative vitreoretinopathy compared with cultured retinal pigment epithelial cells.
Abe T; Durlu YK; Tamai M
Exp Eye Res; 1996 Aug; 63(2):201-10. PubMed ID: 8983978
[TBL] [Abstract][Full Text] [Related]
11. Caspase-8-mediated apoptosis in human RPE cells.
Yang P; Peairs JJ; Tano R; Zhang N; Tyrell J; Jaffe GJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3341-9. PubMed ID: 17591907
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
Casaroli-Marano RP; Pagan R; Vilaró S
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
[TBL] [Abstract][Full Text] [Related]
13. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease.
Hollborn M; Iandiev I; Seifert M; Schnurrbusch UE; Wolf S; Wiedemann P; Bringmann A; Kohen L
Curr Eye Res; 2006 Oct; 31(10):863-74. PubMed ID: 17050278
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of RPE cells by alphaB-crystallin siRNA to SAHA-induced stage 1 apoptosis through abolishing the association of alphaB-crystallin with HDAC1 in SC35 speckles.
Noh SJ; Jeong WJ; Rho JH; Shin DM; Ahn HB; Park WC; Rho SH; Soung YH; Kim TH; Park BS; Yoo YH
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4753-9. PubMed ID: 18552382
[TBL] [Abstract][Full Text] [Related]
15. Melatonin counteracts ischemia-induced apoptosis in human retinal pigment epithelial cells.
Osborne NN; Nash MS; Wood JP
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2374-83. PubMed ID: 9804146
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid produces rod photoreceptor selective apoptosis in developing mammalian retina.
Söderpalm AK; Fox DA; Karlsson JO; van Veen T
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):937-47. PubMed ID: 10711716
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
19. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
